HUTCHMED China Ltd files list of directors to HKEX

Reuters
10/15
HUTCHMED China Ltd files list of directors to HKEX

HUTCHMED (China) Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The Board comprises 10 directors, including Dr Dan Eldar as Chairman and Non-executive Director. Executive Directors are Dr Weiguo Su (Chief Executive Officer* and Chief Scientific Officer) and Mr Cheng Chig Fung, Johnny (Acting Chief Executive Officer and Chief Financial Officer). Non-executive Directors are Ms Edith Shih and Ms Ling Yang. Independent Non-executive Directors include Professor Mok Shu Kam, Tony (Senior and Lead Independent Non-executive Director), Dr Renu Bhatia, Dr Chaohong Hu, Professor Tan Shao Weng, Daniel, and Mr Wong Tak Wai. Committee memberships are as follows: - Audit Committee: Dr Renu Bhatia (Member), Dr Chaohong Hu (Member), Mr Wong Tak Wai (Chairman) - Nomination Committee: Dr Dan Eldar (Member), Dr Chaohong Hu (Member), Professor Mok Shu Kam, Tony (Chairman) - Remuneration Committee: Ms Edith Shih (Member), Dr Renu Bhatia (Chairman), Mr Wong Tak Wai (Member) - Sustainability Committee: Mr Cheng Chig Fung, Johnny (Member), Ms Edith Shih (Chairman), Professor Mok Shu Kam, Tony (Member) - Technical Committee: Dr Dan Eldar (Member), Dr Weiguo Su (Member), Dr Renu Bhatia (Member), Dr Chaohong Hu (Member), Professor Tan Shao Weng, Daniel (Member), Professor Mok Shu Kam, Tony (Chairman) *Dr Weiguo Su is currently on leave from his duties.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HUTCHMED (China) Ltd. published the original content used to generate this news brief on October 15, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10